Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Brihat Dantapala Kera is a traditional Ayurvedic medicated oil primarily indicated for the management of chronic skin conditions such as psoriasis, dermatitis, and eczema. The formulation is an enhanced (Brihat) version of the standard Dantapala oil, typically featuring the leaves of *Wrightia tinctoria* (Dantapala) processed in a base of coconut oil (*Cocos nucifera*). It exhibits potent anti-inflammatory, antimicrobial, and skin-soothing properties. The active phytochemicals in *Wrightia tinctoria*, including triterpenoids and flavonoids, are believed to regulate the excessive proliferation of keratinocytes and reduce the scaling and itching associated with psoriatic lesions. The coconut oil base acts as an emollient, providing a protective barrier and deep hydration to the affected skin. It is also frequently employed for scalp conditions like dandruff and fungal infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Brihat Dantapala Kera.